Value Assessment Patient-Centered Outcomes Challenge Award
As a part of its overall Value Assessment Initiative, the Pharmaceutical Research and Manufacturers of America Foundation, Inc. (PhRMA Foundation) has established the Value Assessment Challenge Awards to help promote leadership and innovative approaches to determining value in health care.
A key challenge in accounting for patient-centered outcomes and impacts in value assessment is the lack of existing data (e.g., clinical trials, observational data sources) and data collection tools (e.g., prospective EMR data collection) to measure outcomes important to patients.
We invite submissions based on bold and creative ideas to advance methods and process associated with value assessment (and/or value elements).
One Time Award
Upper: $50,000USD Lower: $5,000USD
- The winner will receive $50,000
- The runner up will receive $25,000
- Third place will receive $5,000
The PhRMA Foundation will not support evaluations of specific health care interventions.
The award is a one-time award that is payable to an individual, shared among a team or an institution/organization. Award monies may be used as the recipient wishes – there are no restrictions imposed by the PhRMA Foundation. A 1099 will be issued for tax purposes.
Award recipients are expected to publish their work. The PhRMA Foundation will facilitate broad distribution of published papers through a multi-faceted visibility campaign.
- Award opportunities are open to all individuals and organizations with a specialization in health economics, outcomes research, clinical sciences, health care evaluation, public health, health equity or related disciplines.
- Eligible applicants (or collaborators) should be affiliated with an academic institution in the United States, U.S. patient group or organization focused on improving health care in the U.S.
- Collaboration across stakeholder groups and fields of discipline is encouraged.
- The Value Assessment Initiative encourages new researchers to apply for funding. Researchers and collaborators who have received a Value Assessment Award or funding from the PhRMA Foundation in 2020, 2021 or 2022 are not eligible to apply.
- Website